Carmona Jose 4

What Happened Jose Carmona, Chief Financial Officer of ADC Therapeutics (ADCT), received an award of 203,700 restricted stock units (RSUs) on June 30, 2026. The Form 4 reports the RSUs at $0.00 per unit (code A — award/grant); each RSU is a contingent right to one share of common stock and no cash was exchanged at grant.

Key Details

• Transaction date: June 30, 2026; Form 4 filed July 2, 2026 (reporting period listed as 2026-06-30). No late filing indicated in this report.
• Security and amount: 203,700 RSUs granted, reported at $0.00 per RSU.
• Shares owned after transaction: Not disclosed in this filing.
• Vesting note (from filing): RSUs vest on the earlier of (i) June 30, 2027 or (ii) termination by the issuer without cause or by the reporting person for good reason, subject to continued employment. Each RSU converts into one share upon vesting.
• Transaction code: A = Award/Grant of RSUs (not a purchase or sale).

Context RSU grants are a common form of executive compensation and are subject to vesting conditions; they do not represent immediate market purchases or sales. Because these RSUs convert to shares only if/when they vest, the grant itself should be viewed as compensation/retention-related rather than a direct market-confidence signal.